The latest update is out from PuraPharm Corp. Ltd. ( (HK:1498) ).
PuraPharm Corporation Limited has announced the postponement of its board meeting originally scheduled for March 27, 2025, to March 28, 2025. The delay is due to the need for additional time to finalize the company’s annual results for the year ended December 31, 2024, which are crucial for considering the approval of annual financial statements and potential dividend payments.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It is primarily focused on the development and production of Chinese medicine products and health supplements.
YTD Price Performance: 1.82%
Average Trading Volume: 69,716
Technical Sentiment Signal: Buy
Current Market Cap: HK$221.2M
See more insights into 1498 stock on TipRanks’ Stock Analysis page.